Images
Participants
Contact
The business section of “La Vanguardia”, in addition to other media and organizations, have highlighted the Consolidator Grant awarded by the European Research Council (ERC) to the project led by ICREA researcher Xavier Salvatella, head of the Molecular Biophysics Laboratory at IRB Barcelona. The results of this project could lead to new drugs for prostate cancer.
“La Vanguardia” (in Catalan) and digital press dossier
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
